Table 1 Patients baseline characteristic information
Index | Cohort (n = 19) |
|---|---|
Age, y, mean ± SD | 29.1 ± 9.1 |
Male, n (%) | 11 (57.9) |
Montreal classification, n (%) | |
Age at diagnosis | |
< 16 | 0 (0) |
16–40 | 17 (89.5) |
> 40 | 2 (10.5) |
Behavior | |
B1 | 1052.6) |
B2 | 5 (26.3) |
B3 | 4 (21.1) |
Location | |
L1 | 2 (10.5) |
L2 | 1 (5.3) |
L3 | 16 (84.2) |
L4 | 0 (0) |
Disease duration, y, mean ± SD | 5.5 ± 4.7 |
BMI at diagnosis, mean ± SD | 19.5 ± 2.4 |
EIM, n (%) | 1 (5.3) |
Perianal disease, n (%) | 10 (52.6) |
Previous biologics exposure, n (%) | 17 (89.5) |
1 | 15 (78.9) |
2 | 1 (5.3) |
3 | 0 (0) |
4 | 1 (5.3) |
Intestinal surgeries, n (%) | 8 (42.1) |
Concomitant drugs, n (%) | |
Corticosteroid | 1 (5.3) |
Thiopurine | 1 (5.3) |
UST administration interval, n (%) | |
Q12w | 14 (73.7) |
Q8w | 5 (26.3) |